Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS. Long-acting injectable (LAI) HIV medications are reshaping how ...

A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described the virus as hiding in a “latent reservoir,” a group of infected cells that ...

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable - and worrisome -traces ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Centers for Disease Control and Prevention (CDC) has updated its ...

For years, Nigeria’s fight against HIV has centred on testing, treatment and condom use. However, a new chapter is emerging ...

A major hurdle to curing people of HIV infection is the way the virus hides in a reservoir composed primarily of dormant immune cells. It is generally believed that HIV does not replicate in these ...

A new UCLA study reveals that breast milk from women living with HIV contains significantly lower levels of tryptophan, an essential amino acid likely important for infant immune function, growth, and ...

After decades of dashed hopes, AIDS vaccine developers are allowing themselves some cautious optimism. At a conference this week in Bangkok, Thailand, scientists reported molecular clues that help to ...

Researchers may have finally answered the question of why many antibodies that target the HIV envelope are still unable to stop the virus from spreading -- a troublesome stumbling block in the ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists uncover active HIV-infected cells during treatment, using a new tool called HIV-seq to reveal how the virus persists.